News Chart Purple Biotech Ltd

Equities

PPBT

IL0007650166

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 15:24:27 06/06/2024 BST			5-day change	1st Jan Change
21.4 ^ILa	-3.17%		-22.46%	-32.92%

06-01	Purple Biotech Ltd Announces Positive Late-Breaking Interim Randomized Phase 2 Data at ASCO 2024 Demonstrating CM24 Improved Overall Survival and Other Efficacy Endpoints in Pancreatic Cancer	CI
04-25	Purple Biotech Ltd.'s Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting	CI

258d3bf133371421f714a82f08.WT5YwPRjgL5jsix7K3YFA6uzLjqPmzWCKCKb5gpNvz8.DHQ5mJ4o48ZX_Ro2fzw8QcLeTG7nw1PXRW7VjXtg-mAYbSyUnSzh_QzYGA~da875c26bc4caab51ba67282bd828e98